Robyn Domsic

Investigating Environmental Exposures in Systemic Sclerosis in a US Observational Cohort Study.

National Institute of Arthritis and Musculoskeletal and Skin Diseases · K24

Contact PI · $176.6K · University of Pittsburgh at Pittsburgh

Clinical-Translational Studies in Skin, Lung, and Vascular Complications in Systemic Sclerosis

National Institute of Arthritis and Musculoskeletal and Skin Diseases · P50

Project lead · $1.3M · University of Pittsburgh at Pittsburgh

Transforming Autoimmune Diagnostic and Disease Monitoring with a Scalable IP-to-MS Platform for Autoantigen Profiling

National Institute of Allergy and Infectious Diseases · R43

PI · $320.9K · Impact Proteomics, Llc

Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic Disease

National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01

Contact PI · $655.4K · University of Pittsburgh at Pittsburgh

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

Principal investigator · Recruiting

Robyn T. Domsic, MD, MPH

Apollo Device for Fatigue in Systemic Sclerosis

Principal investigator · Completed

Robyn T. Domsic, MD, MPH

Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)

Study chair · Completed · Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)

Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis

Site PI · Recruiting · Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)